- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/40 - Hydrolases (3.) acting on glycosyl compounds (3.2) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase
Patent holdings for IPC class C12N 9/40
Total number of patents in this class: 273
10-year publication summary
18
|
16
|
16
|
22
|
22
|
20
|
25
|
20
|
20
|
11
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Translate bio, Inc. | 416 |
28 |
Amicus Therapeutics, Inc. | 351 |
18 |
Genzyme Corporation | 1277 |
14 |
Crosswalk Therapeutics, Inc. | 13 |
10 |
Novozymes A/S | 3329 |
9 |
Protalix Ltd. | 51 |
9 |
JCR Pharmaceuticals Co., Ltd. | 221 |
8 |
Wyeth Holdings LLC | 54 |
7 |
Takeda Pharmaceutical Company Limited | 2705 |
6 |
Research Foundation of the City University of New York | 423 |
6 |
Vib VZW | 883 |
6 |
Sangamo Therapeutics, Inc. | 420 |
6 |
Hanmi Pharm. Co., Ltd. | 574 |
5 |
Modernatx, Inc. | 1284 |
5 |
University of Maryland, College Park | 1024 |
5 |
The Trustees of the University of Pennsylvania | 4337 |
4 |
Battelle Energy Alliance, LLC | 590 |
4 |
Altif Laboratories | 4 |
4 |
Indiana University Research and Technology Corporation | 800 |
4 |
Tokyo Metropolitan Institute of Medical Science | 112 |
4 |
Other owners | 111 |